• In early August 2026, Henry Schein, Inc. reported Q2 2026 results showing higher sales of US$3,458 million and increased earnings per share, while also raising its full-year 2026 total sales growth guidance to a 4.5%–5.5% range.
• At the same time, the company unveiled a new leadership structure and integrated global supply chain with distribution operations, signaling an effort to improve execution and efficiency alongside its upgraded outlook.
• Next, we’ll examine how the upgraded 2026 sales growth guidance may influence Henry Schein’s existing investment narrative and risk profile.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Henry Schein Investment Narrative Recap

To own Henry Schein, you need to be comfortable with a distributor steadily shifting toward higher margin technology and specialty solutions while managing pricing pressure and uneven dental demand. The raised 2026 sales growth guidance to 4.5%–5.5% supports the near term catalyst around improving execution, but it does not remove the biggest risk, which is whether management can deliver on its broader cost and value creation plans without disrupting operations.

The creation of the Henry Schein Leadership Team and the integration of global supply chain with distribution are especially relevant here, because they sit at the heart of those cost and efficiency ambitions. These changes could influence how effectively Henry Schein supports its higher margin businesses and executes on guidance, but they also add another layer of execution risk that shareholders will want to watch closely.

Yet behind the stronger 2026 sales guidance, investors should still be aware of…

Henry Schein's narrative projects $14.9 billion revenue and $653.3 million earnings by 2029. This requires 3.8% yearly revenue growth and about a $258 million earnings increase from $395.0 million today.

Uncover how Henry Schein's forecasts yield a $88.07 fair value, in line with its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were already assuming revenue of about US$15.7 billion and earnings of roughly US$671 million by 2029, so compared with the consensus narrative they are baking in a much faster ramp in profitability that may or may not be supported once the higher 2026 guidance and new leadership structure are fully reflected in updated views.

Explore 2 other fair value estimates on Henry Schein - why the stock might be worth as much as 83% more than the current price!

Decide For Yourself

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Henry Schein research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Henry Schein research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Henry Schein's overall financial health at a glance.

Looking For Alternative Opportunities?

Our daily scans reveal stocks with breakout potential. Don't miss this chance:

• AI is about to change healthcare. These 42 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Find 50 companies with promising cash flow potential yet trading below their fair value.
• Uncover the next big thing with 20 elite penny stocks that balance risk and reward.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.